Zions Bancorporation N.A. Sells 32 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Zions Bancorporation N.A. cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 25.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 92 shares of the company’s stock after selling 32 shares during the quarter. Zions Bancorporation N.A.’s holdings in HCA Healthcare were worth $37,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Bangor Savings Bank lifted its stake in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC grew its holdings in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare in the second quarter worth about $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,155 shares of company stock worth $5,608,990. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on HCA shares. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 6th. KeyCorp dropped their target price on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. UBS Group boosted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, TD Cowen reduced their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.00.

HCA Healthcare Trading Down 0.7 %

Shares of HCA stock opened at $342.96 on Friday. The company has a market cap of $86.87 billion, a PE ratio of 15.40, a price-to-earnings-growth ratio of 1.34 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock’s 50 day simple moving average is $385.11 and its two-hundred day simple moving average is $357.25. HCA Healthcare, Inc. has a 1 year low of $238.82 and a 1 year high of $417.14.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.